rs3730305
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000603.5(NOS3):c.2112+36C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0847 in 1,551,254 control chromosomes in the GnomAD database, including 6,666 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1344 hom., cov: 33)
Exomes 𝑓: 0.081 ( 5322 hom. )
Consequence
NOS3
NM_000603.5 intron
NM_000603.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.45
Publications
9 publications found
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-151007312-C-A is Benign according to our data. Variant chr7-151007312-C-A is described in ClinVar as Benign. ClinVar VariationId is 1257050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOS3 | NM_000603.5 | c.2112+36C>A | intron_variant | Intron 17 of 26 | ENST00000297494.8 | NP_000594.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18170AN: 152074Hom.: 1336 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
18170
AN:
152074
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0977 AC: 17800AN: 182248 AF XY: 0.0984 show subpopulations
GnomAD2 exomes
AF:
AC:
17800
AN:
182248
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0810 AC: 113258AN: 1399062Hom.: 5322 Cov.: 32 AF XY: 0.0829 AC XY: 57373AN XY: 692284 show subpopulations
GnomAD4 exome
AF:
AC:
113258
AN:
1399062
Hom.:
Cov.:
32
AF XY:
AC XY:
57373
AN XY:
692284
show subpopulations
African (AFR)
AF:
AC:
6904
AN:
32178
American (AMR)
AF:
AC:
2555
AN:
38516
Ashkenazi Jewish (ASJ)
AF:
AC:
2127
AN:
23126
East Asian (EAS)
AF:
AC:
3658
AN:
38818
South Asian (SAS)
AF:
AC:
10725
AN:
80020
European-Finnish (FIN)
AF:
AC:
3700
AN:
36908
Middle Eastern (MID)
AF:
AC:
536
AN:
4954
European-Non Finnish (NFE)
AF:
AC:
77887
AN:
1086550
Other (OTH)
AF:
AC:
5166
AN:
57992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5480
10960
16439
21919
27399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2996
5992
8988
11984
14980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.120 AC: 18198AN: 152192Hom.: 1344 Cov.: 33 AF XY: 0.120 AC XY: 8937AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
18198
AN:
152192
Hom.:
Cov.:
33
AF XY:
AC XY:
8937
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
8577
AN:
41482
American (AMR)
AF:
AC:
1296
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
328
AN:
3472
East Asian (EAS)
AF:
AC:
462
AN:
5178
South Asian (SAS)
AF:
AC:
693
AN:
4830
European-Finnish (FIN)
AF:
AC:
1156
AN:
10610
Middle Eastern (MID)
AF:
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5384
AN:
67994
Other (OTH)
AF:
AC:
246
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
798
1596
2394
3192
3990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
444
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.